Biologics by McKesson is excited to attend ONS Congress® 2026, the industry’s largest and most comprehensive conference dedicated to oncology nursing in the United States. This premier event brings together oncology nurses from across the country to connect, learn and share best practices that advance cancer care and improve patient outcomes.
Biologics by McKesson specialty pharmacy is proud to join industry leaders at Asembia’s AXS26 Summit, taking place April 26-30, 2026, at the Wynn & Encore in Las Vegas. As one of the premier gatherings for the specialty pharmacy and bio-pharmaceutical community, AXS26 brings together thousands of senior decision‑makers shaping the future of patient access.
Biologics by McKesson specialty pharmacy is proud to be a sponsor of the 2026 Informa Connect Access USA Rare Disease Summit, a leading event bringing together key stakeholders to advance rare disease access, innovation, and patient impact.
Biologics by McKesson Specialty Pharmacy is thrilled to be a Bronze level sponsor for the National Association of Specialty Pharmacy 2025 Annual Meeting and Expo September 14 -17, 2025, at the Gaylord Rockies in Denver, CO.
Biologics by McKesson is excited to sponsor the Healthcare Advocate Summit premier event September 2-5, 2025, at Caesars Palace in Las Vegas, NV.
Biologics by McKesson is excited to sponsor Asembia’s AXS25 Summit on April 27 – May 1, 2025, at the Wynn & Encore hotel of Las Vegas. The AXS25 Summit will bring together thousands of decision makers from the nation’s leading pharmacy and pharmaceutical industry as they celebrate 20 years of Leadership.
We are proud sponsors of ONS Congress 2025, as it celebrates 50 years of advancing oncology nursing. Taking place from April 9 – 13 in Denver, Colorado, the Biologics team will be at booth #6050 for insightful discussions on personalized clinical care with our expert team dedicated to enhancing patient outcomes.
Biologics by McKesson is excited to sponsor the 2025 Access USA Rare Disease Summit in Philadelphia. Join us as industry leaders gather to discuss innovative strategies for enhancing patient care in rare diseases and connect with McKesson experts to learn about advancements in patient-centric engagement through technology and interdisciplinary collaboration.